Misra R, Agarwal N
Dept. of Obstetrics & Gynaecology, University College of Medical Sciences, Shahadra Delhi, India.
Indian J Cancer. 1994 Mar;31(1):19-22.
Thirty two cycles of chemotherapy were administered to sixteen patient containing 50-75 mg/msq. of cisplatin. For antiemetic prophylaxis, each patient received metoclopramide alone in the first cycle and a combination of metoclopramide + dexamethasone + lyrazepam in the next cycle. Effective control of emesis was achieved in 81% cycles on the combination antiemetic regime as compared to 19% on MCP alone. There was no statistical difference in the relief of nausea by the two regimens.